CHAMPIONS ONCOLOGY, INC. (CSBR) — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2024)

$56.9M

Net Income/Loss (FY2024)

$4.7M

Total Assets (FY2024)

$32.3M

Total Equity (FY2024)

$3.8M

Cash Flows from Operating Activities (FY2024)

$7.4M

Source: CHAMPIONS ONCOLOGY, INC. 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.